Dexamethasone Intravitreal Implant in Diabetic Macular Edema: Real-Life Data from a Prospective Study and Predictive Factors for Visual Outcome.

Irini P ChatziralliPanagiotis TheodossiadisEfstratios ParikakisEleni DimitriouTina XirouGeorge TheodossiadisStamatina Α Kabanarou

Published in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2017)

The various predictive factors that determine the visual outcome and possibly define patient prognosis after dexamethasone intravitreal implant in DME cases have been studied. The long follow-up showed that dexamethasone intravitreal implant seems to be a safe and effective treatment for this disease, requiring a limited number of injections.

Keyphrases

vascular endothelial growth factor
diabetic retinopathy
high dose
age related macular degeneration
low dose
soft tissue
case report
electronic health record
ultrasound guided
machine learning